C.H. Robinson (CHRW) — insider trading
Industrials
C.H. Robinson (CHRW) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-07-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | Lee Damon J. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 4,698 | $190.95 | $897.1K | Form 4 |
| 2026-06-30 | Gokey Timothy C | Director | Grant / award / vesting (derivative) | 163 | $188.34 | $30.7K | Form 4 |
| 2026-06-30 | Goodburn Mark A. | Director | Grant / award / vesting (derivative) | 193 | $188.34 | $36.3K | Form 4 |
| 2026-06-26 | Bozeman David P | Director, Officer (President & CEO) | Shares withheld for taxes / exercise cost | 11,693 | $180.34 | $2.11M | Form 4 |
| 2026-05-29 | RAJAN ARUN | Officer (Chief Strat & Innov Officer) | Grant / award / vesting | 8,714 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Goodburn Mark A. | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
| 2026-05-07 | GUILFOILE MARY | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
| 2026-05-07 | MCGARRY MICHAEL H | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Robbins Paige K | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Kozlak Jodee A | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Crawford Kermit R | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Tolliver Paula | Director | Grant / award / vesting (derivative) | 992 | $0.00 | $0 | Form 4 |
Ask the chat about CHRW's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: C.H. Robinson (CHRW).
Last updated 2026-07-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.